24
May
Single Cell Analysis of Response and Toxicity Following CD19 CAR T-Cell Therapy in Lymphoma
Going people
Description
Creative BioMart invited Dr. Michael R. Green to join us to provide an overview of scRNA-seq studies that have improved our understanding of CAR T-cell therapy and informed novel approaches to therapeutically target their mechanistic underpinnings.
